Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee
NCT ID: NCT02187549
Last Updated: 2015-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
332 participants
INTERVENTIONAL
2014-06-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hymovis™ Versus Placebo in Knee Osteoarthritis
NCT01372475
A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee
NCT00131352
Evaluation of the Safety of Intraarticular Aquamid Reconstruction Injection for Knee Osteoarthritis in Humans
NCT03060421
Efficacy Study of Intra-articular Hyaluronic Acid in the Knee Osteoarthritis
NCT00556608
A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip
NCT01618708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HYMOVIS
HYADD(TM) 4 Hydrogel Intra-Articular Injection
HYMOVIS
Intra-articular injection
Placebo
Saline Intra-Articular Injection
Placebo
Intra-Articular Injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HYMOVIS
Intra-articular injection
Placebo
Intra-Articular Injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fidia Farmaceutici s.p.a.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Achieve Clinical Research
Birmingham, Alabama, United States
Alabama Clinical Therapeutics
Brimingham, Alabama, United States
Elite Clinical Studies
Phoenix, Arizona, United States
Arizona Research Center
Phoenix, Arizona, United States
Med Center
Carmichael, California, United States
Triwest Research Associates
El Cajon, California, United States
Westlake Medical
Thousand Oaks, California, United States
Colorado Orthopedic Consultants
Englewood, Colorado, United States
Chase Medical
Waterbury, Connecticut, United States
Riverside Clinical Research
Edgewater, Florida, United States
Suncoast Clinical Research
New Port Richey, Florida, United States
Ormond Medical Arts
Ormond Beach, Florida, United States
Tufts Medical Center
Boston, Massachusetts, United States
Great Lakes Research Group
Bay City, Michigan, United States
Healthcare Research Network
Hazelwood, Missouri, United States
Fabio Orozco
Egg Harbor, New Jersey, United States
PMG Research of Raleigh
Raleigh, North Carolina, United States
New Horizons
Cincinnati, Ohio, United States
Columbus Clinical Research
Columbus, Ohio, United States
Blair Orphopedics
Altoona, Pennsylvania, United States
West Houston Clinical Research
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EQE7-13-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.